T 614

Known as: T-614 
 

Topic mentions per year

Topic mentions per year

1992-2017
02419922017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Matrix metalloproteinases (MMPs) have a pivotal role in the destruction of cartilage in rheumatoid arthritis (RA) joint, which is… (More)
Is this relevant?
2009
2009
OBJECTIVE To assess the efficacy and safety of T-614 versus methotrexate (MTX) in patients with active rheumatoid arthritis (RA… (More)
Is this relevant?
2008
2008
INTRODUCTION T-614 is a novel oral antirheumatic agent for the treatment of rheumatoid arthritis. Whether it has immunomodulatory… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
OBJECTIVE To clarify the pharmacological action of an anti-rheumatic agent T-614, we investigated its effects on immunoglobulin… (More)
Is this relevant?
2002
2002
Objective: Compound T-614, a member of the methanesulfoanilide class of anti-inflammatory agents, shows potent anti-arthritic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2002
2002
OBJECTIVE Compound T-614, a member of the methanesulfoanilide class of anti-inflammatory agents, shows potent anti-arthritic… (More)
Is this relevant?
2001
2001
OBJECTIVE To investigate the mechanism of the immunosuppressive effect of T-614 [N-(3-formylamino-4-oxo-6-phenoxy-4H-chromen-7-yl… (More)
Is this relevant?
2000
2000
A group of derivatives of 7-methanesulfonylamino-6-phenoxychromone (1) at the pyrone and phenoxy rings was synthesized starting… (More)
Is this relevant?
1998
1998
In the present study, we examined the therapeutic effects of T-614 (3-formylamino-7-methylsulfonylaminoxy-4H-1-benzopyran-4-one… (More)
Is this relevant?
1995
1995
To elucidate the mechanism for the selective inhibition of prostaglandin E2 (PGE2) production in inflammatory tissue by T-614 (3… (More)
Is this relevant?